IDA only vs Saudi Arabia: Antiretroviral therapy coverage
IDA only
82.5%
in 2024
Saudi Arabia
93.0%
in 2024
IDA only rank
9th
Saudi Arabia rank
11th
Antiretroviral therapy coverage over time
- IDA only
- Saudi Arabia
How they compare
Saudi Arabia currently reports 93.0% against 82.5% in IDA only, a difference of 10.5%.
That makes Saudi Arabia's figure about 1.1 times IDA only's.
Across all 25 years both countries report, Saudi Arabia has been ahead every year.
IDA only ranks 9th and Saudi Arabia ranks 11th of 23 groups.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA only | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.4% | 26.1% | 20.7% | Saudi Arabia |
| 2010s | 43.1% | 57.9% | 14.8% | Saudi Arabia |
| 2020s | 75.6% | 90.0% | 14.4% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, IDA only or Saudi Arabia?
- Saudi Arabia, at 93.0% against 82.5% in IDA only as of 2024.
- What is the difference in antiretroviral therapy coverage between IDA only and Saudi Arabia?
- 10.5%, with Saudi Arabia ahead.
- How many years of comparable data are there for IDA only and Saudi Arabia?
- 25 years are reported by both, from 2000 to 2024.
- How do IDA only and Saudi Arabia rank globally for antiretroviral therapy coverage?
- IDA only ranks 9th and Saudi Arabia ranks 11th of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.